Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model

Journal of Neurochemistry

Volumn 125, Issue 1, 2013, Pages 125-132

  Bains, Mona ^a   Cebak, John E ^a   Gilmer, Lesley K ^a   Barnes, Colleen C ^a   Thompson, Stephanie N ^a   Geddes, James W ^a   Hall, Edward D ^a   Markesbery, William R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

spectrin; calpain; neuroprotection; SNJ 1945; traumatic brain injury

Indexed keywords

[1 [(1 BENZYL 3 CYCLOPROPYLAMINO 2,3 DIOXOPROPYL)CARBAMOYL] 3 METHYLBUTYL]CARBAMIC ACID 2 (2 METHOXYETHOXY)ETHYL ESTER; CALPAIN; FODRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; INJURY SEVERITY; MALE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; BRAIN INJURIES; CALPAIN; CARBAMATES; CEREBRAL CORTEX; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; NEURONS; SPECTRIN;

MUS;

EID: 84875242230     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12118     Document Type: Article

References (29)

1. Ai J., Liu E., Wang J., Chen Y., Yu J., and, Baker A. J., (2007) Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. J. Neurotrauma 24, 960-978.
2. Bartus R., (1997) The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway. Neuroscientist 3, 314-327.
3. Brophy G. M., Pineda J. A., Papa L., et al,. (2009) alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J. Neurotrauma 26, 471-479.
4. Buki A., Siman R., Trojanowski J. Q., and, Povlishock J. T., (1999) The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J. Neuropathol. Exp. Neurol. 58, 365-375.
5. Deng Y., Thompson B. M., Gao X., and, Hall E. D., (2007) Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury. Exp. Neurol. 205, 154-165.
6. Farkas O., Polgar B., Szekeres-Bartho J., Doczi T., Povlishock J. T., and, Buki A., (2005) Spectrin breakdown products in the cerebrospinal fluid in severe head injury-preliminary observations. Acta Neurochir. (Wien) 147, 855-861.
7. Hall E. D., Bryant Y. D., Cho W., and, Sullivan P. G., (2008) Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 25, 235-247.
8. Kampfl A., Posmantur R., Nixon R., Grynspan F., Zhao X., Liu S. J., Newcomb J. K., Clifton G. L., and, Hayes R. L., (1996) mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J. Neurochem. 67, 1575-1583.
9. Kampfl A., Posmantur R. M., Zhao X., Schmutzhard E., Clifton G. L., and, Hayes R. L., (1997) Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J. Neurotrauma 14, 121-134.
10. Koumura A., Nonaka Y., Hyakkoku K., Oka T., Shimazawa M., Hozumi I., Inuzuka T., and, Hara H., (2008) A novel calpain inhibitor, ((1S)-1((((1S)-1- benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-met hylbutyl) carbamic acid 5-methoxy-3-oxapentyl ester, protects neuronal cells from cerebral ischemia-induced damage in mice. Neuroscience 157, 309-318.
11. Kupina N. C., Nath R., Bernath E. E., Inoue J., Mitsuyoshi A., Yuen P. W., Wang K. K., and, Hall E. D., (2001) The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J. Neurotrauma 18, 1229-1240.
12. Kupina N. C., Detloff M. R., Bobrowski W. F., Snyder B. J., and, Hall E. D., (2003) Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury. Exp. Neurol. 180, 55-73.
13. Mbye L. H., Singh I. N., Carrico K. M., Saatman K. E., and, Hall E. D., (2009) Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 87-97.
14. McCracken E., Hunter A. J., Patel S., Graham D. I., and, Dewar D., (1999) Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J. Neurotrauma 16, 749-761.
15. McIntosh T., Saatman K. E., and, Raghupathi R., (1997) Calcium and the pathogenesis of traumatic CNS injury: cellular and molecular mechanisms. Neuroscientist 3, 169-175.
16. Mellgren R., Zhang W., Miyake K., and, McNeil P., (2007) Calpain is required for the rapid, calcium-dependent repair of the wounded plasma membrane. J. Biol. Chem. 282, 2567-2575.
17. Mellgren R., Miyake K., Kramerova I., Spencer M., Bourg N., Bartoli M., Richard I., Greer P., and, McNeil P., (2009) Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases. Biochim. Biophys. Acta 1793, 1886-1893.
18. Mustafa A. G., Wang J. A., Carrico K. M., and, Hall E. D., (2011) Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury. J. Neurochem. 117, 579-588.
19. Oka T., Walkup R. D., Tamada Y., Nakajima E., Tochigi A., Shearer T. R., and, Azuma M., (2006) Amelioration of retinal degeneration and proteolysis in acute ocular hypertensive rats by calpain inhibitor ((1S)-1-((((1S)-1-benzyl-3- cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-me thylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester. Neuroscience 141, 2139-2145.
20. Posmantur R., Kampfl A., Siman R., Liu J., Zhao X., Clifton G. L., and, Hayes R. L., (1997) A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77, 875-888.
21. Saatman K. E., Bozyczko-Coyne D., Marcy V., Siman R., and, McIntosh T. K., (1996a) Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 850-860.
22. Saatman K. E., Murai H., Bartus R. T., Smith D. H., Hayward N. J., Perri B. R., and, McIntosh T. K., (1996b) Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. Natl Acad. Sci. USA 93, 3428-3433.
23. Saatman K. E., Creed J., and, Raghupathi R., (2010) Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 7, 31-42.
24. Shirasaki Y., Yamaguchi M., and, Miyashita H., (2006) Retinal penetration of calpain inhibitors in rats after oral administration. J. Ocul. Pharmacol. Ther. 22, 417-424.
25. Shirasaki Y., Takahashi H., Yamaguchi M., and, Inoue J., (2008) Molecular design to enhance the penetration into the retina via ocular instillation. Bioorg. Med. Chem. Lett. 18, 5174-5177.
26. Thompson S. N., Gibson T. R., Thompson B. M., Deng Y., and, Hall E. D., (2006) Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp. Neurol. 201, 253-265.
27. Thompson S. N., Carrico K. M., Mustafa A. G., Bains M., and, Hall E. D., (2010) A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. J. Neurotrauma 27, 2233-2243.
28. Wang K. K. W., (2000) Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 20-26.
29. Yoshikawa Y., Zhang G. X., Obata K., Ohga Y., Matsuyoshi H., Taniguchi S., and, Takaki M., (2010) Cardioprotective effects of a novel calpain inhibitor SNJ-1945 for reperfusion injury after cardioplegic cardiac arrest. Am. J. Physiol. Heart Circ. Physiol. 298, H643-H651.